CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quidel's Quick Ratio

QDEL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




QDEL Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change 14.37 % 169.42 % 167.66 % 63.47 % 63.21 %
Y / Y Cash & cash equivalent Change 717.24 % 801.95 % 828.36 % 168.2 % 154.22 %
Quick Ratio MRQ 2.83 2.67 1.45 0.37 0.4
Overall Ranking # # # # #
Seq. Current Liabilities Change -42.97 % 8.9 % 62.09 % 13.61 % 34.35 %
Seq. Cash & cash equivalent Change -39.53 % 100.24 % 531.8 % 6.83 % -33.26 %



Quick Ratio second quarter 2021 Comment
Current Liabilities decreased faster than Quidel's Cash & cash equivalent, this led to improvement in Quidel's Quick Ratio to 2.83, Quick Ratio remained below Quidel Corporation average.

Within Biotechnology & Drugs industry 159 other companies have achieved higher Quick Ratio than Quidel in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are QDEL Segments?
See Quick Ratio QDEL on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 160
Healthcare Sector # 565
Overall Market # 1381


Quick Ratio Statistics
High Average Low
6.86 2.48 0.23
(Jun 30 2016)   (Sep 30 2019)




Financial Statements
Quidel's Current Liabilities $ 209 Millions Visit QDEL's Balance sheet
Quidel's Cash & cash equivalent $ 593 Millions Visit QDEL's Balance sheet
Source of QDEL's Sales Visit QDEL's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within Biotechnology & Drugs Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Spero Therapeutics Inc   7.74 $ 99.218  Millions$ 12.826  Millions
Inhibrx Inc   7.46 $ 125.728  Millions$ 16.848  Millions
Akoya Biosciences Inc   7.46 $ 135.464  Millions$ 18.161  Millions
Poseida Therapeutics Inc   7.41 $ 237.261  Millions$ 31.999  Millions
Eargo Inc   7.36 $ 179.354  Millions$ 24.372  Millions
Casi Pharmaceuticals inc   7.28 $ 72.945  Millions$ 10.021  Millions
Royalty Pharma Plc  7.23 $ 2,053.668  Millions$ 283.989  Millions
Soligenix inc   7.23 $ 28.980  Millions$ 4.011  Millions
Intellia Therapeutics Inc   7.15 $ 529.019  Millions$ 73.963  Millions
Neogen Corp  7.11 $ 381.087  Millions$ 53.599  Millions
Taysha Gene Therapies Inc   6.95 $ 197.370  Millions$ 28.391  Millions
Tracon Pharmaceuticals inc   6.90 $ 25.580  Millions$ 3.706  Millions
Adaptimmune Therapeutics Plc  6.89 $ 285.370  Millions$ 41.416  Millions
Evelo Biosciences Inc   6.86 $ 123.333  Millions$ 17.984  Millions
Sanara Medtech Inc   6.74 $ 24.389  Millions$ 3.618  Millions
Idera Pharmaceuticals Inc   6.73 $ 40.590  Millions$ 6.029  Millions
Halozyme Therapeutics Inc   6.61 $ 755.309  Millions$ 114.251  Millions
Brooklyn Immunotherapeutics Inc   6.60 $ 50.680  Millions$ 7.685  Millions
Axcella Health Inc   6.56 $ 78.943  Millions$ 12.034  Millions
Mymd Pharmaceuticals Inc   6.56 $ 21.630  Millions$ 3.299  Millions
Windtree Therapeutics Inc  6.55 $ 29.965  Millions$ 4.574  Millions
Urogen Pharma Ltd   6.35 $ 121.032  Millions$ 19.056  Millions
Aligos Therapeutics Inc   6.33 $ 190.653  Millions$ 30.098  Millions
Unity Biotechnology Inc   6.27 $ 83.943  Millions$ 13.395  Millions
Codiak Biosciences Inc   6.12 $ 113.681  Millions$ 18.588  Millions
Atyr Pharma Inc   6.05 $ 44.061  Millions$ 7.284  Millions
Pluristem Therapeutics Inc  6.02 $ 65.547  Millions$ 10.883  Millions
Biomx Inc   5.96 $ 46.271  Millions$ 7.759  Millions
Heska Corporation  5.91 $ 245.153  Millions$ 41.481  Millions
Madrigal Pharmaceuticals Inc   5.75 $ 323.846  Millions$ 56.307  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CRZN's Profile

Stock Price

CRZN's Financials

Business Description

Fundamentals

Charts & Quotes

CRZN's News

Suppliers

CRZN's Competitors

Customers & Markets

Economic Indicators

CRZN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071